SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dwight martin who wrote (18724)4/6/1998 10:07:00 PM
From: Machaon  Read Replies (1) of 32384
 
<< Rather mentioned what I thought was Raloxifene >>

Thanks. I think that you are correct about this.

<< Made it sound like something was going to happen with pretty quickly with the newer SERMs. >>

Since the emphasis was on "newer" drugs, in the pipeline, I thought that it was a positive for Ligand. They certainly didn't spend the evening saying that Tamoxifen was the cure-all. In fact, there were more questions about the use of Tamoxifen, and side effects, than there were praises.

I was kinda hoping that they would also mention drugs like Targretin, which was just recently compared to Tamoxifen in those naked, and "oh so ugly mice" tests.

Regards, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext